GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1176 - 1200** of **4050** in total

« First

‹ Prev

…

44

45

46

47

48

49

50

51

52

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgA	Patient 3	11	mild	G00054MO	410
IgA	Patient 3	11	mild	G67045LB	410
IgA	Patient 3	11	mild	G89993FE	410
IgA	Patient 3	4	mild	G53168IY	410
IgA	Patient 4	12	mild	G37036SF	410
IgM	Patient 4	12	mild	G08520NM	410
IgA	Patient 1	22	moderate	G82779CI	409
IgA	Patient 1	6	moderate	G08520NM	409
IgA	Patient 1	6	moderate	G17689EW	409
IgA	Patient 1	6	moderate	G89993FE	409
IgM	Patient 2	3	mild	G29011JC	409
IgM	Patient 2	3	mild	G78255UI	409
IgA	Patient 3	4	mild	G00065MO	409
IgA	Patient 1	10	moderate	G31265MS	408
IgA	Patient 1	22	moderate	G24617OK	408
IgA	Patient 2	24	mild	G96557TJ	408
IgM	Patient 2	24	mild	G77974XY	408
IgM	Patient 2	3	mild	G39213VZ	408
IgA	Patient 3	-180	mild	G35446HX	408
IgA	Patient 3	11	mild	G19868AX	408
IgA	Patient 1	22	moderate	G72424VO	407
IgA	Patient 1	6	moderate	G16579HJ	407
IgA	Patient 1	6	moderate	G68703KI	407
IgA	Patient 2	24	mild	G47566FL	407
IgG	Patient 2	15	mild	G49108TO	407